US 12,295,752 B2
Peritoneal dialysis system
Arindam Roy, Bangalore (IN)
Assigned to Mozarc Medical US LLC, Minneapolis, MN (US)
Filed by MOZARC MEDICAL US LLC, Minneapolis, MN (US)
Filed on Jul. 9, 2021, as Appl. No. 17/371,849.
Prior Publication US 2023/0008094 A1, Jan. 12, 2023
Int. Cl. A61B 5/145 (2006.01); A61B 5/00 (2006.01); A61M 1/28 (2006.01)
CPC A61B 5/6866 (2013.01) [A61B 5/14503 (2013.01); A61B 5/14532 (2013.01); A61B 5/4839 (2013.01); A61M 1/282 (2014.02); A61M 1/287 (2013.01)] 19 Claims
OG exemplary drawing
 
1. A method comprising:
controlling, by control circuitry, a peritoneal dialysis (PD) device to deliver PD therapy to a patient during a current PD cycle;
determining, by the control circuitry, a blood glucose level of the patient during the current PD cycle;
determining, by the control circuitry, the blood glucose level is greater than or equal to a predetermined blood glucose level threshold during the current PD cycle;
controlling, by the control circuitry and in response to determining the blood glucose level is greater than or equal to the predetermined blood glucose level threshold, a medical device to deliver insulin to the patient during the current PD cycle; and
in response to the medical device delivering insulin to the patient during the current PD cycle, determining, by the control circuitry a modification to a parameter of the PD therapy during the current PD cycle, wherein the parameter comprises at least one of a dialysate glucose concentration, an alternate osmotic solute concentration, a PD dialysate volume, a PD dialysate dwell time, an ultrafiltration volume, or a number of PD cycles within a time period.